Vivo Efficacy

Related by string. vivo efficacy * Vivos . vivos . VIVO . vivo : Vivo Participacoes NYSE VIV . Also En Vivo . Vivo Participacoes SA . vivo preclinical . Vivo Participacoes . Vivo Participacoes SA VIV / EFFICACY . efficacy : primary efficacy endpoint . secondary efficacy endpoints . antimicrobial efficacy . preclinical efficacy . primary efficacy endpoints . Demonstrates Efficacy * *

Related by context. All words. (Click for frequent words.) 69 Drug Candidate 69 Clinical Trial Results 69 Anti Tumor Activity 69 Mouse Model 68 Antitumor Activity 67 Tumor Growth 67 Present Preclinical Data 67 Vitro Activity 67 Collaborators Publish 67 Survival Benefit 67 Antiviral Activity 67 Tumor Cells 66 Breast Cancer Cells 66 Anti Tumor 66 Shows Promising 66 Cancer Cells 66 Drug Resistant 66 JAK Inhibitor 66 Prolongs Survival 66 Preclinical Data 66 Low Dose 65 Well Tolerated 65 Preclinical Study 65 Shows Promise 65 Smallpox Vaccine 65 Study Evaluating 65 Bacterial Infection 64 Data Suggest 64 Inhibits 64 Immune Cells 64 Immune Responses 64 Lupus Drug 64 Cholesterol Drug 64 Gene Mutation 64 Investigational Compound 64 Induces 64 Meets Primary Endpoint 64 Chronic Hepatitis C 64 Renal Cell Carcinoma 64 Infected Patients 64 Beneficial Effects 64 Breast Cancer Recurrence 64 Statistically Significant 64 Tolerability 64 Arthritis Drug 64 Therapeutic Potential 64 Investigational Agent 64 Drug Shows Promise 64 Presents Preclinical Data 64 Cardiac Function 64 Small Molecule 64 Phase III Clinical Trial 64 Study Showed 64 Therapeutic Vaccines 64 Gout Drug 64 Patients Treated 64 Epilepsy Drug 64 Phase III Trial 64 Malaria Vaccine 64 Pooled Analysis 64 Improves Survival 64 Significantly Improved 64 Novel Mechanism 63 Advanced Colorectal Cancer 63 Advanced Melanoma 63 Phase 2b Study 63 Potentially Fatal 63 Fungal Infections 63 Novel Oral 63 Completes Patient Enrollment 63 Improved Survival 63 Immunogenicity 63 Lung Cancer Drug 63 Osteoporosis Drug 63 Systemic Delivery 63 Monoclonal Antibody 63 Brain Cells 63 Potent Antiviral Activity 63 Blood Vessels 63 Demonstrates Potent 63 Increased Risk 63 Interferon Gamma 63 Significantly Improves 63 Confirms Efficacy 63 Cholesterol Lowering Drug 63 Breast Cancers 63 Experimental Vaccine 63 Detect Cancer 63 Kidney Function 63 Develop Novel 62 Efficacious 62 Immune Response 62 Long Term Efficacy 62 Prostate Tumors 62 Protein Synthesis 62 Topical Treatment 62 Universal Flu Vaccine 62 Phase 2b Clinical Trial 62 Immunogenic 62 Phase IIb Trial 62 Autologous Stem Cell Transplantation 62 Cancer Recurrence 62 Antitumor 62 Anticancer Drug 62 Bacterial Infections 62 Influenza Virus 62 Effectively Treats 62 Demonstrates Efficacy 62 Inflammatory Arthritis 62 Blood Clotting 62 Unfractionated Heparin 62 Previously Treated 62 Metastatic Colorectal Cancer 62 Treated Patients 62 Phase 2a Trial 62 Oritavancin 62 Novel Antibiotic 62 Pharmacokinetic Study 62 Menopausal Women 62 NDA Submission 62 Significantly Reduced 62 Technological Advances 62 Prostate Cancer Patients 62 Insulin Glargine 62 Dendritic Cells 62 Brain Metastases 62 Avian Flu Vaccine 62 Combination Therapy 62 Presents Positive 62 Breast Tumors 62 Rheumatoid Arthritis Drug 62 Kinase Inhibitor 62 Phase 2b Trial 62 Holds Promise 62 Localized Prostate Cancer 62 Investigational Drug 62 Therapeutic Antibody 62 Disease Progression 62 Aggressive Prostate Cancer 62 Demonstrates Statistically Significant 61 Shows Efficacy 61 IND Application 61 Tolerability Study 61 Lipid Levels 61 Drug Combo 61 Monotherapy 61 Heart Stents 61 Drug Resistant Bacteria 61 Combination Treatment 61 Improve Survival 61 Lung Cancer Patients 61 Clinical Outcome 61 Attenuates 61 Liver Tumors 61 Patients Treated With 61 Gastric Cancer 61 Sustained Efficacy 61 Osteoporosis Drugs 61 Synthetic Peptide 61 Appears Safe 61 Genetic Mutations 61 Fat Cells 61 Pediatric Patients 61 FDA Approvals 61 Treating Chronic 61 Demonstrated Significant 61 Multicenter Trial 61 Patients Suffering 61 Pulmonary Arterial Hypertension 61 Improves Outcomes 61 Is Well Tolerated 61 Novel Method 61 Patents Covering 61 Phase III Trials 61 Stomach Cancer 61 Genetic Tests 61 Proves Effective 61 RNAi Therapeutic 61 Impairs 61 Immune Cell 61 Erectile Dysfunction Drug 61 Adjuvant Therapy 61 Prostate Cancer Vaccine 61 Anticancer Activity 61 Protease Inhibitor 61 Predict Risk 61 Rotavirus Vaccine 61 Pivotal Study 61 Could Detect 61 Bare Metal Stents 61 Diabetic Nephropathy 61 Viral Load 61 Demonstrates Significant 61 Stem Cell Treatment 61 Genetic Disorder 61 Long Term Survival 61 Cocaine Addiction 61 HER2 Positive Breast Cancer 61 Skeletal Muscle 61 Osteoporosis Treatment 61 Angiogenic 61 Severe Sepsis 60 Psoriasis Patients 60 Prophylactic Treatment 60 Asthma Treatment 60 Kidney Transplant Patients 60 Stem Cell Transplants 60 Breast Cancer Stem Cells 60 Myelodysplastic Syndromes 60 Shown Effective 60 Double Blind Placebo 60 Sirolimus Eluting Stent 60 Significantly Reduces 60 Provides Clues 60 Meta Analysis 60 Receives Milestone Payment 60 Nicotine Vaccine 60 Cardiovascular Events 60 Patent Covering 60 Inflammatory Markers 60 Advanced Prostate Cancer 60 Knee Osteoarthritis 60 Bird Flu Vaccine 60 Treatment Resistant 60 Orally Active 60 Colorectal Cancer Patients 60 Controlled Study 60 Neoadjuvant Chemotherapy 60 Viral Suppression 60 Clinical Trial Data 60 Placebo Controlled Trial 60 Oral Mucositis 60 Could Prevent 60 Smooth Muscle 60 Gene Silencing 60 Long Term Outcomes 60 Multiple Myeloma Patients 60 Stent Restenosis 60 Lung Cancer Survival 60 Cell Transplants 60 Cholesterol Drugs 60 siRNA Delivery 60 Transdermal Patch 60 Hepatitis B Vaccine 60 Total Knee Arthroplasty 60 Gene Therapy Trial 60 Significant Improvement 60 Detect Breast Cancer 60 Test Detects 60 Adjuvant Chemotherapy 60 Demonstrates Positive 60 Single Dose 60 Blood Thinner 60 Blood Pressure Drug 60 Genetic Mutation 60 Molecular Mechanism 60 Clinical Efficacy 60 Leukemia Cells 60 Pegylated 60 Drug Fails 60 Brain Scans 60 Receives Orphan Drug Designation 60 Radical Prostatectomy 59 Brain Wiring 59 Phase IIa Clinical Trial 59 Rheumatoid Arthritis Patients 59 Dose Response 59 Study Demonstrates 59 Recombinant Human 59 FDA Okays 59 Chronic Hepatitis B 59 Tumor Suppressor 59 Septic Shock 59 Predict Breast Cancer 59 Inhaled Corticosteroids 59 Oral Anticoagulant 59 Atopic Dermatitis 59 Protein Involved 59 Gene Variants 59 Cancer Stem Cells 59 Randomized Clinical Trial 59 IND Filing 59 Chronic Inflammation 59 Dual Antiplatelet Therapy 59 Endometrial Cancer 59 Blood Pressure Lowering 59 Pre Cancerous 59 Hepatitis C Virus 59 Hormonal Therapy 59 Completes Enrollment 59 Prognostic Value 59 Fracture Risk 59 Helps Identify 59 Polymerase Inhibitor 59 Potent Inhibitor 59 Lung Cancers 59 Breast Cancer Patients 59 Successfully Treated 59 Therapeutic Vaccine 59 Tumor Targeting 59 Oral Cavity 59 Breast Cancer Metastasis 59 Vaccine Adjuvant 59 Viral Infections 59 Hepatocellular Carcinoma 59 Initiate Clinical Trial 59 Postmenopausal Women 59 Elderly Patients 59 Therapeutic Efficacy 59 Significant Efficacy 59 Diabetic Patients 59 Protein Expression 59 Receptor Antagonist 59 Neuroprotective Effects 59 Anemia Drug 59 Interferon Beta 59 Nucleoside 59 Blocked Arteries 59 Antiviral Drugs 59 Endovascular Treatment 59 Shows Promise Against 59 Blood Vessel 59 Gene Variation 59 Phase III Clinical Trials 59 Successfully Completes Phase 59 Obese Patients 59 Cancer Treatments 59 Initiates Clinical Trial 59 Adjuvant Treatment 59 Antiangiogenic 59 Ebola Vaccine 59 Regenerative Cells 59 Study Casts Doubt 59 Skin Cells 59 Cancer Diagnosis 59 Diagnostic Tests 59 Treatment Regimen 59 Kidney Transplant Recipients 59 Amniotic Fluid 59 Embryonic Stem Cells 59 Premature Aging 59 Anti Angiogenesis 59 Modulates 59 Hormone Receptor Positive 58 Previously Untreated 58 Epithelial Cells 58 Radiofrequency Ablation 58 Efficacy Results 58 Statin Therapy 58 Suppresses 58 Phase 2a Clinical Trial 58 Hsp# Inhibitor 58 Childhood Leukemia 58 Receptor Agonist 58 Anti Clotting Drug 58 Phase IIb Clinical Trial 58 II Clinical Trial 58 Hemodialysis Patients 58 Novel Therapeutic 58 Adenoma 58 Hepatitis C Patients 58 Gene Mutations 58 Invasive Fungal Infections 58 HCV Protease Inhibitor 58 Interferon Alpha 58 Malignant Melanoma 58 Lanthanum Carbonate 58 Recombinant Protein 58 Peanut Allergies 58 Gene Linked 58 Disease Causing 58 Novel Protein 58 Non Inferiority 58 Hypertensive Patients 58 Nerve Regeneration 58 Iron Deficiency 58 Overactive Bladder 58 Efficacy Trial 58 Genes Linked 58 Patients Undergoing 58 Signaling Pathway 58 Aptamer 58 Drug Resistant HIV 58 Ovarian Cancer Patients 58 Help Diagnose 58 Quadrivalent 58 Cell Proliferation 58 Randomized Phase 58 Tablet Formulation 58 Relapsing Multiple Sclerosis 58 Hormone Therapy 58 Prognostic Significance 58 Prolongs Life 58 Stem Cell Procedure 58 Inflammatory Disease 58 Epoetin Alfa 58 Epidermal Growth Factor Receptor 58 Prognostic Factors 58 Drug Coated Stents 58 Targeted Therapies 58 Chronic Lymphocytic Leukemia 58 Estrogen Therapy 58 Contrast Agent 58 Cervical Cancer Vaccine 58 TB Vaccine 58 Lymph Nodes 58 Venous Thromboembolism 58 Ovarian Cancer Treatment 58 Monoclonal Antibodies 58 Radiation Induced 58 Hormone Refractory Prostate Cancer 58 Deadly Bacteria 58 Newly Diagnosed Multiple Myeloma 58 Treatment Naive 58 Randomized Double Blind 58 Statin Drugs 58 Pivotal Trials 58 Pivotal Phase 58 Tumor Cell 58 Artery Disease 58 Peginterferon Alfa 2a 58 Progenitor Cells 58 Controlled Trial 58 Bone Metastases 58 Randomized Trials 58 Novel Treatments 58 Aliskiren 58 Effective Treatments 58 Metastatic Renal Cell Carcinoma 58 Obtains Exclusive License 58 Rabies Vaccine 58 Treatment Naive HIV 58 Kidney Failure 58 Less Invasive 58 Dose Escalation 57 Treatment Reduces 57 Urine Test 57 Novel Therapies 57 Allogeneic 57 Novel Inhibitor 57 Pivotal Phase III 57 Tumor Suppressor Gene 57 Endothelial Cells 57 Testosterone Patch 57 Nerve Cells 57 Breast Tissue 57 Mental Decline 57 Carotid Stenting 57 Myocardial Ischemia 57 Imaging Technique 57 Renal Function 57 Drug Eluting 57 Metastatic Melanoma 57 Bladder Cancer 57 RNA Interference 57 Magnetic Nanoparticles 57 Suicidality 57 Non Invasive 57 Combination REOLYSIN R 57 Help Detect 57 Cognitive Function 57 Cancer Vaccines 57 Slow Progression 57 Antidepressant Use 57 Skin Cancers 57 Stent Implantation 57 Neuroprotection 57 Stakeholder Opinions 57 Prostate Surgery 57 Hematopoietic Stem Cells 57 Unresectable 57 Catheter Ablation 57 Genetic Variant 57 Versus Placebo 57 Receptor Signaling 57 Circulating Tumor Cells 57 Peripheral Blood 57 Prostate Cancer Surgery 57 Extracellular Matrix 57 Glucose Control 57 Lower Blood Pressure 57 Signaling Pathways 57 Unlock Secrets 57 Brain Atrophy 57 Oxidative Stress 57 RNAi Therapeutics 57 Solid Tumors 57 Antisense Drug 57 Cytotoxicity 57 Randomized Clinical Trials 57 Kidney Transplants 57 Pivotal Trial 57 Thyroid Hormone 57 Influenza Vaccine 57 Inhaled Liposomal Ciprofloxacin 57 Cell Adhesion 57 Inovio Pharmaceuticals 57 Treatment Naive Patients 57 Autoimmune Disorders 57 Antisense 57 Hypercholesterolemia 57 Blood Transfusions 57 Non Invasive Treatment 57 Fixed Dose 57 Human Embryo 57 Demonstrate Significant 57 Trial Evaluating 57 Skin Lesions 57 Extended Release 57 Newly Identified 57 Spider Silk 57 Statistical Significance 57 Stent Thrombosis 57 Thyroid Cancer 57 Genetic Variations 57 Hepatitis C Treatment 57 Stem Cell Treatments 57 Commercialize Novel 57 Microfluidic Devices 57 Capsules CII 57 Chemotherapeutic Agents 57 Renal Cancer 57 Prostate Cancers 57 Refractory Hodgkin Lymphoma 57 Recurrent Breast Cancer 57 Liver Cells 57 Protein Linked 57 Kinase Inhibitors 57 HER2 Positive 57 FDA Approves 57 Diagnosis Treatment 57 Relapsed Multiple Myeloma 56 Prostate Cancer Treatment 56 Mimetics 56 BiTE Antibody 56 Atypical Antipsychotic 56 FDA Cracks Down 56 Metastatic Cancer 56 FDA Approves Drug 56 Genetic Defect 56 Placebo Controlled Study 56 Initiates Phase II 56 Desvenlafaxine Succinate 56 Hold Clues 56 Epithelium 56 Investigational Treatment 56 Antiplatelet Therapy 56 Genetic Predisposition 56 Therapeutic Agents 56 First Patient Dosed 56 Zoledronic Acid 56 Plus Ribavirin 56 Relapsing Remitting Multiple Sclerosis 56 Hematological Cancers 56 Lentiviral 56 Studies Suggest 56 Oral Insulin 56 Cell Differentiation 56 HDAC Inhibitor 56 Clinical Trial Evaluating 56 Oral Fingolimod 56 Initiate Phase 56 MMR Vaccine 56 Heart Failure Patients 56 Preclinical Efficacy 56 Be Studied 56 Partial Onset Seizures 56 Cell Transplant 56 Tyrosine Kinase Inhibitor 56 Commonly Used 56 Drug Prevents 56 Immune Mediated 56 Rectal Cancer 56 Vaccine Adjuvants 56 Researchers Identify 56 Cord Blood Stem Cells 56 Beta Blocker 56 Pneumococcal Vaccine 56 Lymph Node 56 Study Sheds Light 56 Early Diagnosis 56 Cancer Vaccine 56 Pharmacokinetics 56 Platelet Inhibition 56 Hepatic Encephalopathy 56 Brain Tumors 56 Extended Release Formulation 56 Fluorescent Proteins 56 Genes Involved 56 Genes Identified 56 Genetic Testing 56 MRI Scans 56 Induced Pluripotent Stem Cell 56 Carboplatin Paclitaxel 56 Inhibits Growth 56 Survival Rates 56 Patients Receiving 56 Help Predict 56 Colon Polyps 56 Quantum Dots 56 Breast Cancer Treatment 56 Therapy Reduces 56 Preclinical Models 56 Pegylated Interferon 56 Immunologic 56 Neural Stem Cells 56 Lung Cancer Trial 56 Medoxomil 56 Genetic Variation 56 Genes Predict 56 Naive Patients 56 Oligonucleotides 56 Telbivudine 56 Iron Overload 56 Inflammatory Response 56 Fluorouracil 56 Valopicitabine NM# 56 Molecular Diagnostic 56 Eluting Stent 56 Valve Replacement 56 Relapsed Refractory 56 Hepatitis C Genotype 56 Bone Mineral Density 56 Scientists Identify 56 Clinical Evaluation 55 ORLive Presents 55 Tiotropium 55 Bioresorbable 55 Antisense Oligonucleotides 55 Muscle Wasting 55 Than Thought 55 Double Blind Randomized 55 Noninvasive Prenatal 55 Viral Disease 55 Tuberculosis Vaccine 55 Cypher Sirolimus 55 Balloon Angioplasty 55 Autoimmune Diseases 55 Pluripotent Stem Cells 55 Stem Cell Breakthrough 55 Targeted Therapy 55 Underlie 55 Study Pinpoints 55 PKC# 55 Adjunctive Therapy 55 Cancer Therapies 55 Breast Cancer Genes 55 Tumor Targeted 55 Eculizumab 55 Endometrial 55 Companion Diagnostic 55 Androgen Deprivation Therapy 55 Antibiotic Resistance 55 Spectrum Pharmaceuticals Announces 55 Efficacy 55 Safinamide 55 Malignancy 55 Osteoarthritis Patients 55 Protease Inhibitors 55 Preterm Infants 55 Sustained Virologic Response 55 Autoimmune Disease 55 Peginterferon 55 Lung Cancer Treatment 55 TNF Alpha 55 Neural Stem Cell 55 Clinical Validation 55 CYPHER R Sirolimus Eluting 55 Sirolimus Eluting 55 Diabetic Neuropathy 55 Initiates Phase 55 Transfection 55 Ischemic Stroke 55 Drug Resistant Tuberculosis 55 Parathyroid Hormone 55 Liver Cirrhosis 55 Demonstrates Sustained 55 Lymphoid 55 Bortezomib 55 Progenitor Cell 55 Inflammatory Diseases 55 Coronary Arteries 55 Arthritis Drugs 55 Molecular Basis 55 Protein Biomarkers 55 Phase III Pivotal Trial 55 Can Predict 55 Enlarged Prostate 55 Bone Marrow Stem Cells 55 Hematopoietic 55 Predict Prostate Cancer 55 Insights Into 55 Novel Antibody 55 Treat Heart Failure 55 Kidney Stones 55 Adefovir 55 Glufosfamide 55 Mouse Models 55 Curing Cancer 55 Inactivation 55 Portal Hypertension 55 Lung Tumor 55 Epratuzumab 55 Randomized Study 55 Transdermal Delivery 55 Nerve Cell 55 Lung Tumors 55 Safety Tolerability 55 Tumor Progression 55 Pharmacodynamics 55 Predict Response 55 Glatiramer Acetate 55 Multicenter Phase 55 Randomized Placebo Controlled Trial 55 Brain Function 55 HCV Genotype 55 Tumor Markers 55 Minimally Invasive Treatment 54 Spinal Fluid 54 Single Molecule 54 Prospective Randomized 54 Cancer Biomarkers 54 Electroporation 54 Interferon Alfa 54 Cardiovascular Outcomes 54 Single Molecules 54 Gut Bacteria 54 Potency 54 DNA Methylation 54 Eluting 54 Derived Stem Cells 54 Reprogrammed 54 Clinical Study 54 Phenotypes 54 Hepatotoxicity 54 Genotypes 54 Carbon Nanotubes 54 Protein Microarrays 54 Severe Asthma 54 Metastatic Prostate Cancer 54 Complete Remission 54 Virologic 54 Sustained Release 54 Bosutinib 54 Colorectal Adenomas 54 Transcription Factor 54 Prospective Randomized Trial 54 Organ Rejection 54 Randomized Phase II 54 Risedronate 54 Fertility Treatments 54 Left Ventricular 54 Transplant Patients 54 Insulin Resistance 54 Immunomodulatory 54 Pharmacokinetics PK 54 Tissue Samples 54 Anticoagulant 54 Replacement Therapy 54 ISTODAX ® 54 Breast Tumor 54 Analytical Tool 54 Sipuleucel T 54 Blood Disorder 54 Hepatocytes 54 Therapeutic Antibodies 54 Hepatocyte 54 Nucleic Acids 54 Self Assembling 54 Advanced Pancreatic Cancer 54 Bevacizumab 54 Be Prevented 54 Novel Compounds 54 Factor Receptor 54 Predictive Value 54 Mutagenesis 54 BARACLUDE R 54 Cervical Dysplasia 54 Myelodysplastic Syndrome MDS 54 Chronic Renal Failure 54 Late Breaker 54 Novel Peptide 54 Complicated Skin 54 Percutaneous Tibial Nerve Stimulation 54 Achieves Primary Endpoint 54 Novel Approach 54 Immunosuppression 54 Pafuramidine 54 Innate Immune 54 Researchers Uncover 54 Antipsychotic Drug 54 Vitamin D Deficiency 54 Gastrointestinal Disorders 54 Male Contraceptive 54 Stem Cell Differentiation 54 Brain Plasticity 54 Randomised Trial 54 Diabetic Foot Ulcer 54 Randomized Controlled Trial 54 Nicotine Addiction 54 Cethromycin 54 Insect Pests 54 Ovarian Cancer Risk 54 Heart Defects 54 Genetic Makeup 54 Lacosamide 54 Bone Grafting 54 Cerebrospinal Fluid 54 Metabolic Disease 54 Capecitabine 54 Pandemic Influenza Vaccines 54 Initiate Phase III 54 Device Helps 54 Protein Interactions 53 Molecular Mechanisms 53 Multicenter Study 53 Liver Cancer 53 Offer Clues 53 Scientists Uncover 53 Enoxaparin 53 Therapeutic Effects 53 Radiofrequency Ablation RFA 53 Genetic Markers 53 Blood Flow 53 Inhibit 53 Monocytes 53 Epithelial Cell 53 Nilotinib 53 Gives Clues 53 Dose Escalation Study 53 Tigecycline 53 Imaging Techniques 53 Surgery Performed 53 Transcriptome 53 Tesamorelin 53 Subgroup Analysis 53 Artificial Skin 53 Induced Pluripotent Stem Cells 53 Secondary Endpoints 53 Efficacy Study 53 Anticancer Drugs 53 Face Transplant 53 Urinary Incontinence 53 Malaria Parasite 53 Node Positive 53 Darbepoetin Alfa 53 Pegylated Liposomal Doxorubicin 53 Bivalirudin 53 Subcutaneous 53 See CLINICAL PHARMACOLOGY 53 Endeavor Drug Eluting 53 Dose Ranging Study 53 Relieve Pain 53 Hematopoietic Stem Cell Transplantation 53 Nucleic Acid 53 Clostridium difficile Infection 53 Peginterferon Alfa 2b 53 Bacterial Cell 53 Findings Suggest 53 Apoptotic 53 Loading Dose 53 Sinus Infections 53 Novel Compound 53 Novel Small Molecule 53 Male Fertility 53 Castration Resistant Prostate Cancer 53 Zinc Finger Nucleases 53 Genetic Diversity 53 Premature Babies 53 Treating Depression 53 Scientists Develop 53 Epithelial 53 Immune System 53 Spinal Fusion 53 Inhibitors 53 Reperfusion Injury 53 Advanced Ovarian Cancer 53 Drug Eluting Stent 53 Ischemic 53 Cardiotoxicity 53 Epitopes 53 Fondaparinux 53 Motility 53 Clinical Outcomes 53 Dasatinib 53 Muscle Function 53 Nasal Spray 53 Tissue Engineered 53 Insulin Sensitivity 53 Adult Stem Cell Therapy 53 Laryngeal Cancer 53 Primary Endpoint 53 Allograft 53 Orthostatic Hypotension 53 Autologous 53 Successfully Treats 53 Biomaterial 53 Renal Impairment 53 Decitabine 53 Immune Function 53 Study Identifies 53 Acute Ischemic Stroke 53 Toxicogenomics 53 Stem Cell Transplant 53 Innate Immunity 52 Liver Transplant Patients 52 Prevent Infection 52 Nebulized 52 Randomized Controlled Trials 52 Blood Stem Cells 52 Protein Biomarker 52 Antipsychotic 52 Immunotherapies 52 Carotid Endarterectomy 52 Neoplasms 52 Relapsed 52 Biomolecules 52 Skin Infections 52 Liposomal 52 Oligonucleotide 52 Renal Artery 52 Fulvestrant 52 Antihypertensive 52 Secondary Hyperparathyroidism 52 Genome Sequence 52 Multicenter Randomized 52 Interferon alpha 2b 52 Adenoma Prevention 52 Cell Derived 52 Calcium Supplements 52 Breast Ovarian Cancer 52 Infarct 52 Male Infertility 52 Diagnostic Tools 52 Pancreatic Islet 52 Intracranial Aneurysms 52 Fluticasone 52 Knee Arthritis 52 Bone Marrow Cells 52 Metastases 52 Denufosol 52 Dosed 52 Often Misdiagnosed 52 Protein Kinase 52 Aflibercept 52 Moxifloxacin 52 Comorbidities 52 Morpholino 52 Chemoprevention 52 Genes Influence 52 Non Responders 52 Tumor Response 52 Menstrual Pain 52 Dapagliflozin 52 Nanomaterial 52 Mitral Valve Repair 52 Antibody 52 Lung Transplants 52 Adverse Event 52 Detect Lung Cancer 52 Antiviral Therapy 52 Adult Stem Cells 52 Negative Consequences 52 Valsartan 52 Colorectal Cancers 52 Vildagliptin 52 Gender Differences 52 Companion Diagnostics 52 Malignancies 52 Xenograft 52 Ligands 52 Randomized Double blind 52 Intravitreal 52 Systematic Review 52 Egg Freezing 52 Randomized Double Blind Placebo 52 Patient Outcomes 52 Regenerative Cell 52 Looks Promising 52 Transplant Patient 52 Transcriptional 52 Image Guided 52 Eszopiclone 52 Tipranavir 52 Opinion Piece Says 52 Inflammatory Pain 52 Retinal Diseases 52 Adjuvant 52 Alternative Treatments 52 Artificial Liver 52 Ribosome 52 PRN FDA Approves 52 Azacitidine 51 Prenatal Diagnosis 51 Solid Tumor 51 Intracellular 51 Stress Urinary Incontinence 51 Mammalian Cells 51 Randomized Comparison

Back to home page